✦ LIBER ✦

35 CONVERT-A multicentre randomised controlled NCRN trial comparing accelerated twice-daily and high dose once-daily thoracic radiotherapy in good performance status (PS), limited small-cell lung cancer (LD SCLC) treated concurrently with cisplatin and etoposide

✍ Scribed by Faivre-Finn, C.; Lorigan, P.; Blackhall, F.; Ashcroft, L.; Lyn, E.; Lee, M.; McMenemin, R.; Mohammed, N.; Price, A.; Stephens, R.; Snee, M.; VanMeerbeck, J.; Woll, P.

Book ID: 118573966
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 45 KB
Volume: 57
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(07)70361-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

167 CONVERT: Concurrent ONce-daily VErsu

167 CONVERT: Concurrent ONce-daily VErsus twice-daily RadioTherapy. A phase III randomised controlled trial for patients with limited stage small cell lung cancer (LS-SCLC) and good performance status

✍ Faivre-Finn, C.; Falk, S. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

CONVERT: Concurrent once-daily versus tw

CONVERT: Concurrent once-daily versus twice-daily radiotherapy A phase III randomised controlled trial for patients with limited stage small cell lung cancer and good performance status

✍ Faivre-Finn, C. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 40 KB

CONVERT: Concurrent once-daily versus tw

CONVERT: Concurrent once-daily versus twice-daily radiotherapy – a new phase III randomised controlled trial for patients with limited-stage small cell lung cancer and good performance status

✍ Faivre-Finn, C.; Falk, S. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 119 KB